Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 3, 2005, Pages 605-608

  Rudolph, Rebecca E ^a,c   Dominitz, Jason A ^a   Lampe, Johanna W ^a   Levy, Lisa ^a   Qu, Pingping ^a   Li, Shuying S ^a   Lampe, Paul D ^a   Bronner, Mary P ^b   Potter, John D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; NONSTEROID ANTIINFLAMMATORY AGENT;

ABERRANT CRYPT FOCI; ADULT; AGED; ARTICLE; CANCER INHIBITION; CANCER RISK; CIGARETTE SMOKING; CLINICAL ARTICLE; COLON BIOPSY; COLONOSCOPY; COLORECTAL CANCER; FAMILY HISTORY; FEMALE; GROWTH INHIBITION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE CRYPT; MALE; PRIORITY JOURNAL; RECTUM MUCOSA; RISK ASSESSMENT; RISK FACTOR; TUMOR GROWTH; TUMOR VOLUME;

ADENOMA; AGE FACTORS; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLONIC DISEASES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; PEDIGREE; RISK FACTORS; SMOKING;

EID: 16844381852     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-04-0058     Document Type: Article

References (24)

1. Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 1987;37:147-51.
2. Shpitz B, Hay K, Medline A, et al. Natural history of aberrant crypt foci. A surgical approach. Dis Colon Rectum 1996;39:763-7.
3. Pretlow TP, O'Riordan MA, Somich GA, Amini SB, Pretlow TG. Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis 1992;13:1509-12.
4. Caderni G, Giannini A, Lancioni L, Luceri C, Biggeri A, Dolara P. Characterisation of aberrant crypt foci in carcinogen-treated rats: association with intestinal carcinogenesis. Br J Cancer 1995;71:763-9.
5. Wargovich MJ, Jimenez A, McKee K, et al. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinogenesis 2000;21:1149-55.
6. Nascimbeni R, Villanacci V, Mariani PP, et al. Aberrant crypt foci in the human colon: frequency and histologic patterns in patients with colorectal cancer or diverticular disease. Am J Surg Pathol 1999;23:1256-63.
7. Shpitz B, Bomstein Y, Mekori Y, et al. Aberrant crypt foci in human colons: distribution and histomorphologic characteristics. Hum Pathol 1998;29:469-75.
8. Adler DG, Gostout CJ, Sorbi D, Burgart LJ, Wang L, Harmsen WS. Endoscopic identification and quantification of aberrant crypt foci in the human colon. Gastrointest Endosc 2002;56:657-62.
9. Bouzourene H, Chaubert P, Seelentag W, Bosman FT, Saraga E. Aberrant crypt foci in patients with neoplastic and nonneoplastic colonic disease. Hum Pathol 1999;30:66-71.
10. Roncucci L, Stamp D, Medline A, Cullen JB, Bruce WR. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol 1991;22:287-94.
11. Takayama T, Katsuki S, Takahashi Y, et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 1998;339:1277-84.
12. Yamashita N, Minamoto T, Ochiai A, Onda M, Esumi H. Frequent and characteristic K-ras activation in aberrant crypt foci of colon. Is there preference among K-ras mutants for malignant progression? Cancer 1995;75:1527-33.
13. Roncucci L, Modica S, Pedroni M, et al. Aberrant cyrpt foci in patients with colorectal cancer. Br J Cancer 1998;77:2343-8.
14. Kristt D, Bryan K, Gal R. Colonic aberrant crypts may originate from impaired fissioning: relevance to increased risk of neoplasia. Hum Pathol 1999;30:1449-58.
15. Hamilton SR, Vogelstein B, Kudo S, et al. Carcinoma of the colon and rectum. In: Hamilton SR, Aaltonen LA, editors. World Health Organization classification of tumors: pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000. p. 105-19.
16. Fenoglio CM, Haggitt RC, Hamilton SR, Lumb G, Pascal RR, Riddell RH. Colonic dysplasia. Pathol Annu 1981;16 Pt 1:181-213.
17. Cochran WG. Sampling techniques. 3rd ed. New York: John Wiley & Sons, Inc.; 1977.
18. Otori K, Konishi M, Sugiyama K, et al. Infrequent somatic mutation of the adenomatous polyposis coli gene in aberrant crypt foci of human colon tissue. Cancer 1998;83:896-900.
19. Pedroni M, Sala E, Scarselli A, et al. Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis. Cancer Res 2001;61:896-9.
20. Augenlicht LH, Richards C, Corner G, Pretlow TP. Evidence for genomic instability in human colonic aberrant crypt foci. Oncogene 1996;12:1767-72.
21. Jen J, Powell SM, Papadopoulos N, et al. Molecular determinants of dysplasia in colorectal lesions. Cancer Res 1994;54:5523-6.
22. Reid BJ, Barrett MT, Galipeau PC, et al. Barrett's esophagus: ordering the events that lead to cancer. Eur J Cancer Prev 1996;5 Suppl 2:57-65.
23. Rabinovitch PS, Dziadon S, Brentnall TA, et al. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Res 1999;59:5148-53.
24. Potter JD. Colorectal cancer: molecules and populations. J Natl Cancer Inst 1999;91:916-32.